| For: | Elaskalani O, Razak NBA, Falasca M, Metharom P. Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer. World J Gastrointest Oncol 2017; 9(1): 37-41 [PMID: 28144398 DOI: 10.4251/wjgo.v9.i1.37] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v9/i1/37.htm |
| Number | Citing Articles |
| 1 |
Mona Tangsiri, Ali Hheidari, Mahsa Liaghat, Mahtab Razlansari, Narges Ebrahimi, Abdullatif Akbari, Seyed Mostafa Noorbakhsh Varnosfaderani, Fahimeh Maleki-Sheikhabadi, Ali Norouzi, Maryam Bakhtiyari, Hamidreza Zalpoor, Mohsen Nabi-Afjadi, Abbas Rahdar. Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT). Biomedicine & Pharmacotherapy 2024; 170 doi: 10.1016/j.biopha.2023.115973
|
| 2 |
Suresh Chava, Meher B. Gayatri, Aramati B.M. Reddy. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. 2019; doi: 10.1016/B978-0-12-817661-0.00003-2
|
| 3 |
Camille Huart, Jia-Wei Chen, Benjamin Le Calvé, Carine Michiels, Anne-Catherine Wéra. Could Protons and Carbon Ions Be the Silver Bullets Against Pancreatic Cancer?. International Journal of Molecular Sciences 2020; 21(13) doi: 10.3390/ijms21134767
|
| 4 |
Ling Xiong, Hong Lu, Ying Hu, Wei Wang, Rong Liu, Xinpeng Wan, Jianjiang Fu. In vitro anti-motile effects of Rhoifolin, a flavonoid extracted from Callicarpa nudiflora on breast cancer cells via downregulating Podocalyxin-Ezrin interaction during Epithelial Mesenchymal Transition. Phytomedicine 2021; 93 doi: 10.1016/j.phymed.2021.153486
|
| 5 |
Wenli Liu, Yuqin Wang, Lijie Xia, Jinyao Li. Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer. Nutrients 2024; 16(6) doi: 10.3390/nu16060797
|
| 6 |
Zhihai Yuan, Zhen Yang, Weiqin Li, Aimei Wu, Zhixiang Su, Bin Jiang. Expression of Concern Issued: Exosome-Mediated Transfer of Long Noncoding RNA HOTAIR Regulates Temozolomide Resistance by miR-519a-3p/RRM1 Axis in Glioblastoma. Cancer Biotherapy and Radiopharmaceuticals 2020; doi: 10.1089/cbr.2019.3499
|
| 7 |
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk, Rosa Angela Cardone. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Cancers 2022; 14(10) doi: 10.3390/cancers14102486
|
| 8 |
Lingyun Wu, Sugandha Saxena, Rakesh K. Singh. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1224 doi: 10.1007/978-3-030-35723-8_1
|
| 9 |
远哲 荣. Research Progress on Reversing Oxaliplatin Resistance in Colon Cancer. Advances in Clinical Medicine 2023; 13(08) doi: 10.12677/ACM.2023.1381779
|
| 10 |
Lingyun Wu, Sugandha Saxena, Mohammad Awaji, Rakesh K. Singh. Tumor-Associated Neutrophils in Cancer: Going Pro. Cancers 2019; 11(4) doi: 10.3390/cancers11040564
|
| 11 |
Ying-Sheng Xiao, De Zeng, Yuan-Ke Liang, Yang Wu, Mei-Fang Li, Yu-Zhu Qi, Xiao-Long Wei, Wen-He Huang, Min Chen, Guo-Jun Zhang. Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells. Cancer Letters 2019; doi: 10.1016/j.canlet.2018.09.031
|
| 12 |
Nusrat J. Epsi, Sukanya Panja, Sharon R. Pine, Antonina Mitrofanova. pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma. Communications Biology 2019; 2(1) doi: 10.1038/s42003-019-0572-6
|
| 13 |
Sofia Kamlund, Birgit Janicke, Kersti Alm, Robert L. Judson-Torres, Stina Oredsson. Quantifying the Rate, Degree, and Heterogeneity of Morphological Change during an Epithelial to Mesenchymal Transition Using Digital Holographic Cytometry. Applied Sciences 2020; 10(14) doi: 10.3390/app10144726
|
| 14 |
Thomas Brabletz, Raghu Kalluri, M. Angela Nieto, Robert A. Weinberg. EMT in cancer. Nature Reviews Cancer 2018; 18(2) doi: 10.1038/nrc.2017.118
|
| 15 |
Hesham A. El-Mahdy, Ahmed M. Mohamadin, Ahmed I. Abulsoud, Emad Gamil Khidr, Ahmed A. El-Husseiny, Ahmed Ismail, Elsayed G.E. Elsakka, Hamada Ahmed Mokhlis, Hussein M. El-Husseiny, Ahmed S. Doghish. miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses. Pathology - Research and Practice 2023; 245 doi: 10.1016/j.prp.2023.154457
|
| 16 |
Yongjing Xiang, Qing Zhang, Shujun Wei, Cong Huang, Zhengsheng Li, Yongxiang Gao. Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities. Journal of Pharmacy and Pharmacology 2020; 72(4) doi: 10.1111/jphp.13204
|
| 17 |
Bikash Chandra Jena, Siddik Sarkar, Lipsa Rout, Mahitosh Mandal. The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance. Cancer Letters 2021; 520 doi: 10.1016/j.canlet.2021.08.002
|
| 18 |
Yue Yu, Fei Ding, Meng Gao, Yi Jia, Le Ren. Establishment and characterization of the gemcitabine‑resistant human pancreatic cancer cell line SW1990/gemcitabine. Oncology Letters 2019; doi: 10.3892/ol.2019.10627
|
| 19 |
Xiaomeng Zhang, Ningyi Ma, Weiqiang Yao, Shuo Li, Zhigang Ren. RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancer. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-1077-6
|
| 20 |
Lisa-Marie Philipp, Umut-Ulas Yesilyurt, Arne Surrow, Axel Künstner, Anne-Sophie Mehdorn, Charlotte Hauser, Jan-Paul Gundlach, Olga Will, Patrick Hoffmann, Lea Stahmer, Sören Franzenburg, Hendrike Knaack, Udo Schumacher, Hauke Busch, Susanne Sebens. Epithelial and Mesenchymal-like Pancreatic Cancer Cells Exhibit Different Stem Cell Phenotypes Associated with Different Metastatic Propensities. Cancers 2024; 16(4) doi: 10.3390/cancers16040686
|
| 21 |
. 2019; doi: 10.70675/9e4a869fz06fdz4efbz8853zfcd3e85c03e4
|
| 22 |
Zhaoyan Qiu, Yi Chu, Bing Xu, Qian Wang, Mingzuo Jiang, Xiaowei Li, Gang Wang, Pengfei Yu, Guoxiao Liu, Hua Wang, Huijie Kang, Jiayu Liu, Yu Zhang, Jian-Ping Jin, Kaichun Wu, Jie Liang. Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinoma. Oncotarget 2017; 8(34) doi: 10.18632/oncotarget.17701
|
| 23 |
Shuo Yu, Min Wang, Hang Zhang, Xingjun Guo, Renyi Qin. Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis. Genes 2021; 12(11) doi: 10.3390/genes12111701
|
| 24 |
Rita Zilhão, Hélia Neves. Molecular and Cell Biology of Cancer. Learning Materials in Biosciences 2019; doi: 10.1007/978-3-030-11812-9_9
|
| 25 |
Zhaotao Wang, Zhi Liu, Guoyong Yu, Xiaohu Nie, Weiqiang Jia, Ru-en Liu, Ruxiang Xu. Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor β-Induced Epithelial–Mesenchymal Transition. Neurochemical Research 2018; 43(3) doi: 10.1007/s11064-018-2478-y
|
| 26 |
Siyi Zhang, Xiaoxuan Li, Xiang-Xue Li, Zi-Heng Zhang, Kai-Hui Zhu, Jing Guo. Development of a ferroptosis-related signature and identification of NOTCH2 as a novel prognostic biomarker in pancreatic cancer. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1659652
|
| 27 |
Xiaoqing Wan, Jiaxin Hou, Shurong Liu, Yanli Zhang, Wenqing Li, Yanru Zhang, Yi Ding. Estrogen Receptor α Mediates Doxorubicin Sensitivity in Breast Cancer Cells by Regulating E-Cadherin. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.583572
|
| 28 |
Kylie Belanger, Samantha Guinn, Brayan Perez, Yeonju Cho, Joseph A. Tandurella, Mili Ramani, Jae W. Lee, Daniel J. Zabransky, Emma Kartalia, Jignasha Patel, Haley Zlomke, Norman G. Nicolson, Nicole E. Gross, Sarah M. Shin, Benjamin C. Barrett, Samantha Sun, Nicholas Sun, Ethan Firth, Alexei G. Hernandez, Erin M. Coyne, Courtney D. Cannon, Eunji Moon, Soren Charmsaz, Ludmila Danilova, James M. Leatherman, Melissa R. Lyman, Jacob T. Mitchell, Lei Zheng, Michael G. Goggins, Kelly J. Lafaro, Jin He, Christopher R. Shubert, William R. Burns, Elana J. Fertig, Luciane T. Kagohara, Elizabeth M. Jaffee, Richard A. Burkhart, Won Jin Ho, Jacquelyn W. Zimmerman. Cancer-Associated Fibroblasts Promote Epithelial–Mesenchymal Transition and Classical to Basal Subtype Shift in Pancreatic Cancer. Cancer Research 2026; 86(14) doi: 10.1158/0008-5472.CAN-25-0331
|
| 29 |
Yong Gao, Jinhui Liu, Baobao Cai, Qun Chen, Guangfu Wang, Zipeng Lu, Kuirong Jiang, Yi Miao. Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation. Bioengineered 2021; 12(2) doi: 10.1080/21655979.2021.2000197
|
| 30 |
Zhengjun Lin, Shiyao Lu, Xubin Xie, Xuyang Yi, He Huang. Noncoding RNAs in drug-resistant pancreatic cancer: A review. Biomedicine & Pharmacotherapy 2020; 131 doi: 10.1016/j.biopha.2020.110768
|
| 31 |
Yu-Shen Yang, Dan Wen, Xue-Feng Zhao. Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis—in vitro and in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(6) doi: 10.1007/s00210-020-02032-8
|
| 32 |
De Zeng, Yuan‐Ke Liang, Ying‐Sheng Xiao, Xiao‐Long Wei, Hao‐Yu Lin, Yang Wu, Jing‐Wen Bai, Min Chen, Guo‐Jun Zhang. RETRACTED: Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple‐negative breast cancer cells. International Journal of Cancer 2020; 147(2) doi: 10.1002/ijc.32911
|
| 33 |
Nan Wang, Jingwen Xu, Gang Wang, Pikun Cao, Xin Ye. Pancreatic intra-arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma: A pilot study. Journal of Cancer Research and Therapeutics 2022; 18(7) doi: 10.4103/jcrt.jcrt_819_22
|
| 34 |
Aleksandra Adamska, Omar Elaskalani, Aikaterini Emmanouilidi, Minkyoung Kim, Norbaini Binti Abdol Razak, Pat Metharom, Marco Falasca. Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. Advances in Biological Regulation 2018; 68 doi: 10.1016/j.jbior.2017.11.007
|
| 35 |
Mohini Singh, Nicolas Yelle, Chitra Venugopal, Sheila K. Singh. EMT: Mechanisms and therapeutic implications. Pharmacology & Therapeutics 2018; 182 doi: 10.1016/j.pharmthera.2017.08.009
|
| 36 |
Xia Ma, Bei Wang, Xiaofang Wang, Yujiao Luo, Wufang Fan, Masaru Katoh. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells. PLOS ONE 2018; 13(4) doi: 10.1371/journal.pone.0192436
|
| 37 |
Tuan Luu. Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.646399
|
| 38 |
Reegan Sturgeon, Paran Goel, Caitlin Molczyk, Ridhi Bhola, Paul M. Grandgenett, Michael A. Hollingsworth, Rakesh K. Singh. Neutrophil Dynamics Contribute to Disease Progression and Poor Survival in Pancreatic Cancer. Cancers 2025; 17(21) doi: 10.3390/cancers17213541
|
| 39 |
Ming-Bo Huang, Dara Brena, Jennifer Y. Wu, William W. Roth, Samuel Owusu, Vincent C. Bond. Novel secretion modification region (SMR) peptide exhibits anti-metastatic properties in human breast cancer cells. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17534-z
|
| 40 |
Aarif Siddiqui, Paolo Ceppi. A non-proliferative role of pyrimidine metabolism in cancer. Molecular Metabolism 2020; 35 doi: 10.1016/j.molmet.2020.02.005
|
| 41 |
Hye-ran Moon, Altug Ozcelikkale, Yi Yang, Bennett D. Elzey, Stephen F. Konieczny, Bumsoo Han. An engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutations. Lab on a Chip 2020; 20(20) doi: 10.1039/D0LC00707B
|
| 42 |
James H. Monkman, Erik W. Thompson, Shivashankar H. Nagaraj. Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease. Cancers 2019; 11(11) doi: 10.3390/cancers11111745
|
| 43 |
Mir Owais Ayaz, Aadil Qadir Bhat, Zaheen Akhter, Neetu Badsera, Md Mehedi Hossain, Farheen Showket, Sabra Parveen, Mohmmad Saleem Dar, Harshita Tiwari, Nedhi Kumari, Mahir Bhardwaj, Razak Hussain, Ashutosh Sharma, Mukesh Kumar, Umed Singh, Amit Nargorta, Aravind Singh Kshatri, Utpal Nandi, Satdarshan Pal Monga, P. Ramajayan, Parvinder Pal Singh, Mohd Jamal Dar. Identification of a novel GSK3β inhibitor involved in abrogating KRas dependent pancreatic tumors in Wnt/beta-catenin and NF-kB dependent manner. Life Sciences 2024; 351 doi: 10.1016/j.lfs.2024.122840
|
| 44 |
LiYa Huang, BinWu Ma, JunWen Ma, Feng Wang. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway. Biochemical and Biophysical Research Communications 2017; 493(4) doi: 10.1016/j.bbrc.2017.10.006
|
| 45 |
Abdul K. Siraj, Poyil Pratheeshkumar, Sasidharan Padmaja Divya, Sandeep Kumar Parvathareddy, Rong Bu, Tariq Masoodi, Yan Kong, Saravanan Thangavel, Nasser Al-Sanea, Luai H. Ashari, Alaa Abduljabbar, Samar Al-Homoud, Fouad Al-Dayel, Khawla S. Al-Kuraya. TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC. Molecular Cancer Therapeutics 2019; 18(7) doi: 10.1158/1535-7163.MCT-18-1378
|
| 46 |
Marco Cordani, Raffaele Strippoli, Álvaro Somoza. Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment. Cancers 2019; 12(1) doi: 10.3390/cancers12010025
|
| 47 |
|
| 48 |
Rimsha Kanwal, Jessica Elisabetta Esposito, Bilal Jawed, Syed Khuram Zakir, Riccardo Pulcini, Riccardo Martinotti, Matteo Botteghi, Francesco Gaudio, Stefano Martinotti, Elena Toniato. Exploring the Role of Epithelial–Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review. Cancers 2025; 17(3) doi: 10.3390/cancers17030529
|
| 49 |
Miran Rada, Migmar Tsamchoe, Audrey Kapelanski-Lamoureux, Nour Hassan, Jessica Bloom, Stephanie Petrillo, Diane H. Kim, Anthoula Lazaris, Peter Metrakos. Cancer Cells Promote Phenotypic Alterations in Hepatocytes at the Edge of Cancer Cell Nests to Facilitate Vessel Co-Option Establishment in Colorectal Cancer Liver Metastases. Cancers 2022; 14(5) doi: 10.3390/cancers14051318
|